Page last updated: 2024-08-24

1,2-distearoyllecithin and Hypertension, Pulmonary

1,2-distearoyllecithin has been researched along with Hypertension, Pulmonary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alving, CR; Baranyi, L; Basta, M; Bodo, M; Bünger, R; Morse, DS; Savay, S; Stahl, GL; Szebeni, J1

Other Studies

1 other study(ies) available for 1,2-distearoyllecithin and Hypertension, Pulmonary

ArticleYear
Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:3

    Topics: Animals; Antibodies; Cholesterol; Complement Activation; Complement C3a; Complement C5a; Dimyristoylphosphatidylcholine; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Humans; Hypertension, Pulmonary; Immunoglobulins, Intravenous; Infusions, Intravenous; Injections, Intravenous; Linear Models; Liposomes; Male; Particle Size; Phosphatidylcholines; Phosphatidylglycerols; Swine

2000